Ballabgarh in north Indian state of Haryana could come up in the world map for an altogether new reason: The village has perhaps the lowest number of Alzheimer's disease risk in the world, according to a report.

US FDA has asked Daiichi-controlled Ranbaxy to undertake concrete steps to ensure that all of the company's facilities involved in manufacturing products to US market confirm with the regulator's cGMP requirements.

Prices of drugs to treat cancer and AIDS could become cheaper in India as the government is proposing a total customs duty waiver for these life-saving drugs in the budget fiscal year 2010-11, reports said.

The government of India has brought into effect stricter norms for obtaining No Objection Certificates (NOCs) for pharmaceutical exporters.

The controversial anti-obesity drug sibutramine could be banned in India, reports said.

India’s biotherapeutics leader Biocon Ltd could see a more competition in the prospestive oral insulin pills market as more such formulation including the latest investigational insulin capsule ORMD-0801 from Oramed Pharmaceuticals Inc entered the crucial phase of clinical studies.

India may begin vaccination against H1N1 swine flu in the country by March this year as the first batches of imported vaccine from Sanofi-Pasteur will arrive India by the end of February.

An Indian court has asked the government to intervene and control the prices of life-saving drugs sold in the country acting on a petition filed by a veteran playback singer.

H1N1 swine flu market in India is expected to see heightened action in the coming months as  more and more companies join the fray to launch own versions of the vaccine in the country.

India's biotherapeutics leader Biocon Ltd is seeking approval from US FDA to conduct clinical trials for its oral insulin product code-named IN 105, reports said.